Article History
Accepted: 17 February 2022
First Online: 5 March 2022
Declarations
:
: None.
: No financial support was received for the conduct of this study and preparation of the manuscript.
: All authors are fulltime employees of AstraZeneca and are shareholders in the company.
: Not applicable.
: Not applicable.
: All authors consent to publication of this manuscript.
: Rating of each website by the raters is available upon request.
: Not applicable.
: MYS conceptualized the research questions and wrote both the first and final versions of the manuscript. MYS and SF co-developed the analysis plan. SF conducted the data analysis, and contributed to manuscript writing and preparation. RM reviewed the EMC and REMS@FDA websites, prepared the data for analysis and contributed to manuscript writing. JF reviewed successive drafts of the manuscript. All authors participated in assessing the quality of the risk minimization websites. In addition, all authors read and approved the final version of the manuscript.